ALPHAMAB-B(09966) issued 146,000 shares due to the exercise of options.
CanSino Biologics Inc. -B (09966) announced that on November 27, 2025, 146,000 shares were issued due to the exercise of options.
ALPHAMAB-B (09966) announces that on November 27, 2025, 146,000 shares were issued due to the exercise of options.
Related Articles
GOLDEN LEAF INT (08549) announced its interim results, with a net loss attributable to shareholders of HKD 3.604 million, a year-on-year change from profit to loss.
UNI PRINTSHOP (08448) released its mid-term results, with a net profit attributable to shareholders of HKD 3.39 million, representing a year-on-year increase of 9.35%.
IMPERIUM FIN GP (08029) announces interim results, with a net loss attributable to owners of 17.104 million Hong Kong dollars, a decrease of 20.56% year-on-year.
GOLDEN LEAF INT (08549) announced its interim results, with a net loss attributable to shareholders of HKD 3.604 million, a year-on-year change from profit to loss.
UNI PRINTSHOP (08448) released its mid-term results, with a net profit attributable to shareholders of HKD 3.39 million, representing a year-on-year increase of 9.35%.
IMPERIUM FIN GP (08029) announces interim results, with a net loss attributable to owners of 17.104 million Hong Kong dollars, a decrease of 20.56% year-on-year.
RECOMMEND
Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025
Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025
Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025
